Synaps

Developing novel photodynamic therapies for neurosurgery

Synaps
  • About
    • Overview
    • Partnership >
      • Onco-THAI Inserm U1189
      • University of Lille
      • Lille University Hospital
      • Inserm
      • ECRIN
      • Leitat Technological Center
      • IDDI
      • Medical University of Graz
      • OP2
      • Erasme Hospital
  • Research
    • Overview
    • Clinical trial
    • Publications
  • Medical information
    • Overview
    • Glioblastoma
    • PhotoDynamic Therapies
  • News
  • Contact

  • About
    • Overview
    • Partnership >
      • Onco-THAI Inserm U1189
      • University of Lille
      • Lille University Hospital
      • Inserm
      • ECRIN
      • Leitat Technological Center
      • IDDI
      • Medical University of Graz
      • OP2
      • Erasme Hospital
  • Research
    • Overview
    • Clinical trial
    • Publications
  • Medical information
    • Overview
    • Glioblastoma
    • PhotoDynamic Therapies
  • News
  • Contact

News

Photodynamic therapy in Neurosurgery  at the ASLMS 2018 annual congress in Dallas, TX

4/15/2018

 
OncoThAI researchers presented their latest works during the ASLMS 2018 conference in Dallas

This year again, the presence of OncoThAI researchers was noticed during the 38th ASLMS Congress (American Society of Laser In Medicine and Surgery).

This edition confirmed the involvement of the OncoThAI both in terms of organization and scientific dissemination. Indeed, Prof. Serge Mordon, head of OncoThAI was co-chairman in charge of the scientific program and several papers on photodynamic therapy were presented during oral sessions.

These sessions were the occasion of scientific presentations by Dr. Maximilien Vermandel on the implementation of INDYGO clinical trial and round tables on PDT. The next edition of this conference will be held in Denver in 2019.
Facebook LinkedIn Twitter

Comments are closed.
Université Lille 2
Onco Thai
Inserm
CHRU Lille
Picture
 Legal notice - Credits